GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Gross profit (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $24.2B | +6.9% | 2.9% | −2.1% |
| Gross profit (TTM) | $24.2B |
|---|---|
| YoY | +6.9% |
| 5-year CAGR | 2.9% |
| 10-year CAGR | −2.1% |
Gross profit
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $23.2B | +3.1% |
| 2024 | $22.5B | +9.1% |
| 2023 | $20.6B | −4.7% |
| 2022 | $21.6B | +4.4% |
| 2021 | $20.7B | +2.9% |
| 2020 | $20.1B | +13.2% |
| 2019 | $17.8B | +2.9% |
| 2018 | $17.3B | −20.5% |
| 2017 | $21.7B | −16.8% |
| 2016 | $26.1B | −8.7% |
| 2015 | $28.6B | +35.7% |
| 2014 | $21.1B | +152.9% |
| 2013 | $8.3B | +15.4% |
| 2012 | $7.2B | +15.5% |
| 2011 | $6.3B | +3.0% |
| 2010 | $6.1B | +12.3% |
| 2009 | $5.4B | +28.7% |
| 2008 | $4.2B | +21.6% |
| 2007 | $3.5B | — |